查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1853479

抗凝血灭鼠剂市场按类型、剂型、作用机制、目标囓齿动物种类、最终用户和应用划分－全球预测，2025-2032年

Anticoagulant Rodenticides Market by Type, Formulation, Mode Of Action, Target Rodent, End User, Application Method - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，抗凝血灭鼠剂市场规模将成长 29.6 亿美元，复合年增长率为 13.99%。

关键市场统计数据
基准年2024年 10.3亿美元
预计年份：2025年 11.8亿美元
预测年份 2032 29.6亿美元
复合年增长率（%） 13.99%

这份简明扼要的介绍面向相关人员，概述了影响抗凝血灭鼠剂市场格局的关键问题、监管压力和科学复杂性。

抗凝血灭鼠剂市场是一个错综复杂的领域，涉及化学、生态学、监管环境和商业性需求等许多面向。从製剂生产商和农民到市政害虫防治项目和住房服务提供商，相关人员必须应对不断变化的关于药效和抗药性的科学证据、日益增长的环境管理期望，以及日益重视非目标生物保护和上市后监测的法规环境。

在此背景下，有效的推广至关重要：灭鼠剂不仅仅是产品类型，而是一套涵盖毒理学、应用方法、物种行为和供应链可靠性的综合实践系统。活性成分化学和製剂技术的最新进展正在改变操作预期，而应用基础设施（例如诱饵站设计和防篡改投放）的相应发展趋势，则将价值重心转移到综合服务产品上。

因此，决策者在选择产品和设计方案时，应重点关注活性成分的选择、作用机制、目标囓齿动物的生物学特性以及最终用户的需求之间的兼容性。这项观点确立了本报告的核心前提：使抗凝血剂的技术特性与价值链中各相关人员的监管要求和优先事项保持一致，才能实现持久的害虫防治效果。

对价值链中产品开发、阻力动态、环境政策和相关人员期望等方面的变革性转变进行了深刻剖析。

抗凝血灭鼠剂市场正经历技术、监管和市场主导的变革时期。分子毒理学和监测技术的进步提高了对亚致死效应和二次暴露途径的检测能力，促使监管机构和采购商重新评估可接受的风险阈值。同时，囓齿类抗药性模式的显着变化也迫使产品开发商重新评估其优先考虑的化学品类型以及其上市产品所配套的管理措施。

随着科学的进步，采购行为也不断演变。大型农业和市政采购商越来越要求提供可验证的环境保障措施、减少非目标生物暴露的证据以及供应链透明度。因此，供应商正致力于配方创新，以提高偏好和目标生物的靶向性，同时最大限度地减少环境残留。此外，数位化监测和诱饵站遥测技术的整合正在重塑服务模式，使其朝向基于结果的合约模式转变，在这种模式下，有效性指标和事件报告是商业性关係的核心。

总而言之，这些转变正在创造一种新的竞争动态。能够将可靠的毒理学数据、负责任的应用系统和清晰的监管路径相结合的组织，将更有利于赢得长期合约并主导倡议。在这种环境下，对科学发现的快速回应和积极参与法律规范不再是可选项，而是商业性韧性的基石。

对2025年美国累积关税措施及其对抗凝血灭鼠剂企业的营运、供应链和合规影响进行重点分析

美国在2025年前实施的累积关税政策对製造业、分销业和应用服务业产生了直接且连锁的影响。进口成本的增加促使一些经销商重新评估其供应商多元化策略，寻求更靠近产地的原料和成品，以降低贸易政策波动带来的风险。同时，关税也改变了采购时机，许多买家在保单生效前加快采购，而另一些买家则寻求与多家供应商签订合约以分散风险。

在营运方面，关税凸显了供应链透明度和合约弹性的重要性。拥有更紧密的公司间物流、更强的国内製造能力和长期供应商协议的企业受到的衝击较小，而依赖单一来源进口的企业则面临更大的库存和利润压力。此外，与商品分类、文件编制和海关通讯协定相关的合规成本也迫使监管、采购和商务团队更加紧密地合作，以避免运输延误和潜在的执法行动。

从策略角度来看，关税环境提升了情境规划的价值，包括对投入成本波动的敏感度、紧急采购计划，以及审查配方方案以便在监管和疗效允许的情况下进行替代。决策者现在将贸易政策视为影响成本结构以及产品上市、註册续约和监管计画部署时间表的关键因素。

以数据主导的细分洞察，将类型、配方、作用机制、目标物种、最终用户和应用方法转化为决策者的策略重点。

有效的策略细分始于产品类型，并将技术属性转化为营运优先事项。与第二代抗凝血剂（Chlorophacinone、Coumatetralyl灵、敌鼠钠盐、敌鼠钠盐、Warfarin）相比，第一代抗凝血剂（氯鼠灵、Bromadiolone、敌鼠钠盐、Difethialone鼠Flocoumafen）的疗程往往较短，且用药管理模式也不同。这种差异会影响抗药性管理、环境暴露以及最终用户的选择。

所研究的製剂——块状、颗粒状、液体状、糊状和丸剂——每种製剂都有独特的应用和偏好特征，从而影响产品的使用地点和方式。作用机制分类阐明了生化标靶：香豆素类药物——溴敌隆、Bromadiolone灵、Coumatetralyl、Difethialone酮、Flocoumafen、氟香豆素和Warfarin——与茚满二酮类药物——Chlorophacinone、二鼠灵和吡啶酮——形成对比。

目标物种细分——以小鼠、大鼠、松鼠和田鼠为目标——决定了製剂选择和施用方法，因为物种特异性的摄食和栖息地行为决定了最佳施用效果。最终用户细分——农业、商业、工业、市政和居民区——决定了监管暴露、可接受的残留特征和管理预期。最后，对诱饵站、洞穴诱饵、液体诱饵和散装诱饵等施用方法的探索——塑造了操作规程和风险管理框架。整合这些方面，建立了一个以细分为主导的框架，支援差异化的产品定位和有针对性的风险缓解策略。

整合美洲、欧洲、中东和非洲以及亚太市场的需求驱动因素、管理体制和物流限制的区域情报

区域动态对管理体制、营运风险和商业策略有重大影响。在美洲，相关人员需要在强劲的农业需求和日益严格的环境审查之间寻求平衡。采购往往优先考虑营运可靠性和成本效益，而监管机构则强调非目标影响的缓解和事故报告。因此，供应链强调快速分销、本地化技术支援以及符合联邦和州政府要求的管理计划。

欧洲、中东和非洲的监管体系各不相同，其中许多规定都涉及环境持久性和二次暴露。这种差异性要求提供细緻的监管资讯和量身定制的产品管理措施。许多欧洲、中东和非洲地区的司法管辖区都非常重视监测和报告，製造商通常需要根据不同国家的标准调整标籤检视、可接受的配方和应用指南。因此，这些地区的市场准入取决于监管机构的积极回应和相关人员的持续参与。

在亚太地区，快速的都市化、多样化的农业实践以及日益增长的粮食安全担忧推动了需求成长，并影响着可接受的管理实践。供应链物流在不同地区可能有显着差异，商业公司必须考虑分销基础设施的差异以及执法力度的差异。在所有地区，成功的策略都取决于技术能力与当地监管要求和最终用户偏好的契合度，同时保持灵活性以应对特定地区的突发事件管理需求。

对抗凝血灭鼠剂领域中推动创新、管理和商业策略的主要企业进行竞争概况和能力评估

抗凝血灭鼠剂领域的竞争地位取决于活性成分和配方创新、完善的监管管理系统、监管专业知识以及分销能力。领先企业持续投入产品监管、透明的环境风险沟通，并与施用器和市政采购人员伙伴关係，以在整个价值链中贯彻最佳实践。这种做法有助于降低声誉风险，并支持以可衡量的监管成果为依据的长期合约。

除了技术领先之外，商业性差异化往往源自于一体化服务模式。提供捆绑式解决方案的供应商，例如将优化配方与诱饵站基础设施、监测服务和培训相结合的供应商，能够与重视结果保障的大型机构买家建立密切合作关係。同样，那些建立严谨的内部合规团队并积极与监管机构沟通的公司，可以加快註册续期流程，并在司法管辖区变更时协助完成标籤变更。

分销策略同样至关重要。拥有多元化物流、区域仓储以及与农业合作社和市政采购部门建立强大管道的公司，往往能在贸易中断时期保持更高的供应能力和应对力。最终，竞争优势在于那些将科学信誉、卓越营运、强有力的管理以及调整商业模式以适应不断变化的法规和买家期望的能力相结合的企业。

提出切实可行的、优先考虑的建议，以降低监管风险、优化配方、加强管理，并使商业模式与永续性要求保持一致。

行业领导者应采取一系列优先行动，将监管意识和科学知识转化为营运韧性和商业性优势。首先，应建立一个跨职能的监管委员会，将毒理学、法规事务、供应链和销售部门联繫起来，以确保配方选择、标籤更新和应用指南在不同司法管辖区保持一致。这种一体化的管治将缩短合规时间，并有助于向买家和监管机构传递一致的通讯。

第二，透过采购多元化和增强供应合约的灵活性，降低关税和贸易政策带来的风险。尽可能投资本地製造业和战略伙伴关係关係，以减少对易受影响的进口管道的依赖。第三，加速采用精准投放系统和基于实证的应用通讯协定，以减少非目标物种的暴露，并支持与监管机构的有效沟通。投资诱饵站远端检测和经过验证的监测通讯协定，可以展现可衡量的成果，并吸引机构投资者的注意。

第四，优先与监管机构和最终用户进行透明沟通，并公布管理数据和事件回应程序。这种透明度有助于建立信任，并降低受到惩罚的可能性。最后，在功效和法律规范允许的情况下，探索低残留配方，并设计培训计划，确保不同最终用户群正确应用，从而使商业性产品与永续发展目标保持一致。这些措施共同打造了永续性的市场地位，同时满足了日益影响采购决策的环境和监管优先事项。

对调查方法、资料来源和分析框架的清晰阐述，确保了研究的严谨性和可重复性，并为相关人员提供决策层面的洞见。

这些研究成果结合了定性和定量方法，以确保分析的严谨性和可重复性。主要分析包括对毒理学、产品开发、法规事务和害虫管理领域的专家进行访谈，以了解实际操作情况和新出现的挑战。次要分析则综合了同侪审查文献、官方监管文件和技术指导文件，以揭示活性成分的行为、抗药性报告和最佳管理实践。

本研究采用的分析框架包括：产品比较分析，旨在将活性成分属性与生态学持久性和非目标风险相匹配；細項分析，旨在将应用方法与物种行为联繫起来；以及情境规划，旨在评估不同贸易政策环境下供应链的韧性。数据检验透过多资讯来源三角验证和专家专案评审来实现，以确保分析结果反映当前的行业实践。

我们始终强调调查方法假设和限制的透明度。在摘要各司法管辖区的监管细节时，调查方法会关注不同的方法，并着重指出需要进行本地咨询的领域。这种调查方法的选择既有助于提供决策层面的洞见，又能认识到在敏感的监管情况下需要进行针对特定司法管辖区的后续跟进。

这是一份综合分析报告，它将监管、技术、商业和区域等各个方面联繫起来，为行业领导者和政策制定者提供切实可行的建议。

我们的总结报告综合考虑了监管趋势、技术差异、供应链现状和区域差异，旨在强调价值链各环节领导者必须关注的要点。首先，科学发展和抗药性监测凸显了持续投资于活性成分管理和应用创新的重要性。其次，贸易政策的变化和关税压力表明，供应链设计和采购的灵活性是一项策略要务，它直接影响商业性可行性。

第三，更清晰的市场区隔——按产品类型、配方、作用机制、目标物种、最终用户和应用方法划分——能够实现更精准的产品定位和风险规避。第四，区域动态凸显了市场准入和持续推广需要细緻的监管资讯和在地化的营运模式。综上所述，这些发现预示着该产业未来的发展方向是：将功效、环境管理、监管参与和供应链韧性视为相互融合的优先事项，而非各自独立的工作。

因此，决策者应优先考虑跨职能协作，投资远端检测和监控，并追求供应商多元化和区域营运能力，以此作为策略支柱，使组织能够应对当前的合规挑战，并在政策和生态学条件不断变化的情况下保持持续的领导地位。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 增加可生物降解的抗凝血灭鼠剂饵料的开发，以实现永续的害虫防治
  • 囓齿类动物对第一代Warfarin抗凝血剂产生抗药性，促使相关研究和开发工作加速进行。
  • 透过整合物联网智慧监测系统优化抗凝血诱饵投放。
  • 美国环保署收紧对溴敌隆的限制将鼓励向风险较低的活性成分替代品过渡。
  • 生物防治和化学防治相结合的综合虫害管理策略正得到越来越广泛的应用
  • 商用灭鼠剂电子商务分销的增加正在扰乱传统的供应链。
  • 奈米封装技术的开发旨在提高抗凝血剂的稳定性和靶向释放。
  • 都市区宠物饲养趋势推动了对宠物安全型抗凝血灭鼠剂的需求激增

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 抗凝血灭鼠剂市场（按类型划分）

  • 第一代
    • Chlorophacinone
    • Coumatetralyl
    • 敌鼠酮
    • 皮多内
    • Warfarin
  • 第二代
    • Brodifacoum
    • Bromadiolone
    • 敌敌畏
    • Difethialone
    • Flocoumafen

9. 依配方分類的抗凝血灭鼠剂市场

  • 堵塞
  • 粮食
  • 液体
  • 贴上
  • 颗粒

第十章：抗凝血灭鼠剂市场依作用机制划分

  • 香豆素
    • Brodifacoum
    • Bromadiolone
    • Coumatetralyl
    • 敌敌畏
    • Difethialone
    • Flocoumafen
    • Warfarin
  • 印丹吉翁
    • Chlorophacinone
    • 敌鼠酮
    • 皮多内

第十一章 抗凝血灭鼠剂市场目标囓齿动物

  • 老鼠
  • 鼠
  • 松鼠
  • 田鼠

第十二章 依最终用户分類的抗凝血灭鼠剂市场

  • 农业
  • 商业的
  • 产业
  • 市政
  • 住宅

第十三章 依应用分類的抗凝血灭鼠剂市场

  • 诱饵站
  • 洞穴觅食
  • 液体饵料
  • 散饵

第十四章 抗凝血灭鼠剂市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 抗凝血灭鼠剂市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国抗凝血灭鼠剂市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • BASF SE
    • Bayer AG
    • Neogen Corporation
    • PelGar International PLC
    • Syngenta AG
    • FMC Corporation
    • UPL Limited
    • Adama Agricultural Solutions Ltd.
    • Sumitomo Chemical Co., Ltd.
    • Sichuan Sunshine Biotech Co., Ltd.
Product Code: MRR-3A2E844FF1DD

The Anticoagulant Rodenticides Market is projected to grow by USD 2.96 billion at a CAGR of 13.99% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.03 billion
Estimated Year [2025] USD 1.18 billion
Forecast Year [2032] USD 2.96 billion
CAGR (%) 13.99%

A concise introduction framing the critical issues, regulatory pressures, and scientific complexities shaping the anticoagulant rodenticide landscape for stakeholders

The anticoagulant rodenticide landscape presents a complex intersection of chemistry, ecology, regulatory scrutiny, and commercial necessity. Stakeholders ranging from formulators and agricultural operators to municipal pest-control programs and residential service providers must navigate evolving scientific evidence on efficacy and resistance, increasing expectations for environmental stewardship, and a tightening regulatory environment that emphasizes non-target protection and post-market monitoring.

Against this backdrop, an effective introduction reframes the conversation: rodenticides are not solely a product category but a system of practices that couples toxicology with application method, species behavior, and supply chain reliability. Recent advances in active ingredient chemistry and formulation technology have altered operational expectations, while parallel developments in application infrastructure-such as bait-station design and tamper-resistant delivery-have shifted the locus of value toward integrated service offerings.

Consequently, decision-makers should approach product selection and program design with an emphasis on compatibility among active ingredient selection, mode of action, target rodent ecology, and end-user needs. This introductory perspective establishes the central premise of the report: durable pest management outcomes derive from aligning technical properties of anticoagulant solutions with regulatory requirements and stakeholder priorities across the value chain.

An incisive review of transformative shifts redefining product development, resistance dynamics, environmental policy, and stakeholder expectations across the value chain

The landscape for anticoagulant rodenticides is undergoing transformative shifts that are simultaneously technical, regulatory, and market-driven. Advances in molecular toxicology and surveillance have sharpened detection of sublethal effects and secondary exposure pathways, prompting regulators and purchasers to reassess acceptable risk thresholds. At the same time, documented changes in rodent resistance patterns have driven product developers to re-evaluate both the chemical scaffolds they prioritize and the stewardship measures they bundle with commercial offerings.

Parallel to these scientific drivers, procurement behavior is evolving. Large agricultural and municipal buyers increasingly demand demonstrable environmental safeguards, evidence of reduced non-target exposure, and supply chain transparency. As a result, suppliers are investing in formulation innovations that enhance palatability and targeted delivery while minimizing environmental persistence. In addition, integration of digital monitoring and bait-station telemetry is reshaping service models toward outcome-based contracts where efficacy metrics and incident reporting are central to commercial relationships.

Taken together, these shifts are creating new competitive dynamics: organizations that can link robust toxicological profiles with responsible application systems and clear regulatory pathways will be better positioned to capture long-term contracts and to lead stewardship initiatives. In this environment, responsiveness to scientific findings and proactive engagement with regulatory frameworks are no longer optional but foundational to commercial resilience.

A focused analysis of cumulative United States tariff measures enacted in 2025 and their operational, supply chain, and compliance consequences for anticoagulant rodenticide operators

The introduction of cumulative tariff measures in the United States during 2025 has had immediate and cascading implications for operators across manufacturing, distribution, and application services. Increased import costs have prompted some distributors to reassess vendor diversification and to seek nearer-sourced ingredients or finished goods to reduce exposure to trade policy volatility. In parallel, tariffs have shifted procurement timing, with many buyers accelerating purchases ahead of policy milestones and others exploring multi-supplier contracts to spread risk.

Operationally, tariffs have emphasized the importance of supply chain visibility and contractual flexibility. Companies with tighter intercompany logistics, domestic manufacturing capabilities, or long-term supplier agreements have experienced fewer disruptions, while those reliant on single-source imports have faced heightened inventory and margin pressures. Additionally, compliance costs associated with classification, documentation, and customs protocols have required closer collaboration between regulatory, procurement, and commercial teams to avoid shipment delays and potential enforcement actions.

From a strategic standpoint, the tariff environment has reinforced the value of scenario planning: sensitivity to input-cost fluctuation, contingency sourcing plans, and revisiting formulation options to allow substitution where regulatory and efficacy considerations permit. Decision-makers now view trade policy as a material factor that affects not only cost structures but also timelines for product launches, registration renewals, and stewardship program rollouts.

Data-driven segmentation insights that translate type, formulation, mode of action, target species, end user, and application method into strategic priorities for decision makers

Effective strategic segmentation requires translating technical attributes into operational priorities, beginning with product type. First Generation anticoagulants-studied across Chlorophacinone, Coumatetralyl, Diphacinone, Pindone, and Warfarin-tend to be associated with shorter persistence and different stewardship profiles compared with Second Generation agents, which are studied across Brodifacoum, Bromadiolone, Difenacoum, Difethialone, and Flocoumafen and often present greater potency and persistence considerations. This dichotomy has implications for resistance management, environmental exposure, and end-user selection.

Formulation choices further refine strategy; formulations studied across Blocks, Grain, Liquid, Paste, and Pellets each carry unique application and palatability characteristics that influence where and how products are deployed. The mode of action categorization clarifies biochemical targeting: Coumarin compounds-further studied across Brodifacoum, Bromadiolone, Coumatetralyl, Difenacoum, Difethialone, Flocoumafen, and Warfarin-contrast with Indanedione agents-further studied across Chlorophacinone, Diphacinone, and Pindone-in terms of metabolic pathways and implications for resistance monitoring.

Target species segmentation across Mice, Rats, Squirrels, and Voles drives both formulation selection and application method, because species-specific foraging and habitat behaviors determine optimal delivery. End-user segmentation across Agricultural, Commercial, Industrial, Municipal, and Residential contexts dictates regulatory exposure, acceptable residual profiles, and stewardship expectations. Finally, application methods studied across Bait Stations, Burrow Baiting, Liquid Baiting, and Loose Bait shape operational protocols and risk management frameworks. Integrating these dimensions yields a segmentation-led framework that supports differentiated product positioning and targeted risk mitigation strategies.

Regional intelligence synthesizing demand drivers, regulatory regimes, and logistical constraints across the Americas, Europe, Middle East & Africa, and the Asia-Pacific markets

Regional dynamics materially influence regulatory posture, operational risk, and commercial strategies. In the Americas, stakeholders operate in jurisdictions that balance robust agricultural demand with growing environmental scrutiny; procurement tends to prioritize operational reliability and cost-effectiveness, while regulators emphasize non-target impact mitigation and incident reporting. Consequently, supply chains emphasize responsive distribution, localized technical support, and stewardship programs that align with both federal and state-level expectations.

Across Europe, Middle East & Africa, regulatory regimes are diverse and often more prescriptive regarding environmental persistence and secondary exposure. This heterogeneity necessitates granular regulatory intelligence and tailored product stewardship measures. In many EMEA jurisdictions, there is heightened emphasis on monitoring and reporting, and manufacturers frequently need to adapt labeling, allowable formulations, and application guidance to meet disparate national standards. Market access here is therefore dependent on regulatory agility and sustained stakeholder engagement.

In the Asia-Pacific region, demand drivers include rapid urbanization, diverse agricultural practices, and an increasing focus on food security that shapes acceptable control practices. Supply chain logistics can vary widely across the region, and commercial players must account for disparate distribution infrastructure and differing enforcement intensity. Across all regions, successful strategies hinge on aligning technical performance with local regulatory expectations and end-user preferences, while maintaining the flexibility to respond to region-specific incident management requirements.

Competitive profiling and capability assessment of leading companies driving innovation, stewardship, and commercial strategy within the anticoagulant rodenticide sector

Competitive positioning within the anticoagulant rodenticide sector is shaped by a combination of innovation in active ingredients and formulations, strength of stewardship programs, regulatory expertise, and distribution capabilities. Leading organizations demonstrate consistent investment in product stewardship, transparent environmental risk communication, and partnerships with applicators and municipal buyers to embed best practices across the value chain. This approach reduces reputational risk and supports longer-term contracts that hinge on measurable stewardship outcomes.

In addition to technical leadership, commercial differentiation often arises from integrated service models. Suppliers that offer bundled solutions-combining optimized formulation with bait-station infrastructure, monitoring services, and training-achieve closer alignment with large institutional buyers who prioritize outcome assurance. Similarly, companies that cultivate rigorous internal compliance teams and proactive regulatory engagement can accelerate registration updates and smoothly navigate label changes required by jurisdictional shifts.

Distribution strategy also matters: firms with diversified logistics, regional warehouses, and strong channels into agricultural cooperatives and municipal procurement tend to maintain higher availability and responsiveness during periods of trade disruption. Ultimately, competitive advantage accrues to organizations that marry scientific credibility with operational excellence, robust stewardship, and the ability to adapt commercial models to evolving regulatory and buyer expectations.

Actionable, prioritized recommendations to mitigate regulatory risk, optimize formulations, strengthen stewardship, and align commercial models with sustainability imperatives

Industry leaders should adopt a set of prioritized actions that translate regulatory awareness and scientific insight into operational resilience and commercial advantage. First, establish cross-functional stewardship committees that link toxicology, regulatory affairs, supply chain, and sales to ensure that formulation choices, labeling updates, and application guidance remain aligned across jurisdictions. This integrated governance reduces time-to-compliance and supports consistent messaging to buyers and regulators.

Second, diversify sourcing and build flexibility into supply contracts to mitigate tariff and trade-policy exposure. Where feasible, invest in regional manufacturing or strategic partnerships that reduce reliance on vulnerable import routes. Third, accelerate adoption of targeted delivery systems and evidence-based application protocols that reduce non-target exposure and support favorable regulatory engagement. Investing in bait-station telemetry and validated monitoring protocols can demonstrate measurable outcomes that appeal to institutional buyers.

Fourth, prioritize transparent communication with regulators and end-users by publishing stewardship data and incident-response procedures. Such transparency builds trust and reduces the likelihood of punitive actions. Finally, align commercial offerings with sustainability objectives by exploring lower-persistence formulations where efficacy and regulatory frameworks permit, and by designing training programs that ensure correct field application across diverse end-user groups. Collectively, these actions create a defensible market position while addressing the environmental and regulatory priorities that increasingly determine procurement decisions.

Clear exposition of the research methodology, data sources, and analytical frameworks used to ensure rigor, reproducibility, and decision-grade insights for stakeholders

The research underpinning these insights combines qualitative and quantitative approaches designed to ensure analytical rigor and reproducibility. Primary methods include interviews with technical experts across toxicology, product development, regulatory affairs, and pest management practitioners to capture operational realities and emergent challenges. Secondary analysis integrates peer-reviewed literature, public regulatory filings, and technical guidance documents to contextualize active-ingredient behavior, resistance reporting, and stewardship best practices.

Analytical frameworks applied in this work include comparative product profiling that maps active ingredient properties to ecological persistence and non-target risk, segmentation analysis linking application method to species behavior, and scenario planning to evaluate supply chain resilience under alternative trade-policy environments. Data validation is achieved through triangulation across multiple sources and targeted expert review to ensure that interpretations reflect current industry practice.

Throughout, emphasis was placed on transparency of assumptions and methodological limitations. Where jurisdictional regulatory detail is summarized, the methodology notes the range of approaches and highlights areas where local consultation is required. These methodological choices support decision-grade insights while acknowledging the need for jurisdiction-specific follow-up in regulatory-sensitive contexts.

A concluding synthesis that connects regulatory, technical, commercial, and regional threads into pragmatic conclusions for industry leaders and policymakers

The concluding synthesis draws together regulatory trends, technical differentiation, supply chain realities, and regional nuance into a focused set of takeaways for leaders across the value chain. First, scientific developments and resistance monitoring underscore the need for ongoing investment in active-ingredient stewardship and application innovation. Second, trade-policy shifts and tariff pressures demonstrate that supply chain design and sourcing flexibility are now strategic imperatives that directly affect commercial viability.

Third, segmentation clarity-across type, formulation, mode of action, target species, end user, and application method-enables more precise product positioning and risk mitigation. Fourth, regional dynamics affirm that granular regulatory intelligence and localized operational models are essential for market access and sustained uptake. Taken together, these threads point toward an industry future where efficacy, environmental stewardship, regulatory engagement, and supply chain resilience are integrated priorities rather than separate initiatives.

Decision-makers should therefore prioritize cross-functional alignment, invest in telemetry and monitoring, and pursue supplier diversification and regional operational capabilities as core strategic pillars. By doing so, organizations can both meet immediate compliance challenges and position themselves for sustained leadership as policy and ecological conditions continue to evolve.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increased development of biodegradable anticoagulant rodenticide baits for sustainable pest control
  • 5.2. Emergence of rodent populations resistant to first-generation warfarin anticoagulants driving R&D
  • 5.3. Integration of IoT-enabled smart monitoring systems to optimize anticoagulant bait deployment
  • 5.4. Stricter EPA regulations on brodifacoum trigger shift toward low-risk active ingredient alternatives
  • 5.5. Rising adoption of integrated pest management strategies combining biological and chemical controls
  • 5.6. Growth in e-commerce distribution of professional-grade rodenticides impacting traditional supply chains
  • 5.7. Development of nano-encapsulation technologies enhancing anticoagulant stability and targeted release
  • 5.8. Surge in demand for pet-safe anticoagulant rodenticides driven by urban pet ownership trends

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Anticoagulant Rodenticides Market, by Type

  • 8.1. First Generation
    • 8.1.1. Chlorophacinone
    • 8.1.2. Coumatetralyl
    • 8.1.3. Diphacinone
    • 8.1.4. Pindone
    • 8.1.5. Warfarin
  • 8.2. Second Generation
    • 8.2.1. Brodifacoum
    • 8.2.2. Bromadiolone
    • 8.2.3. Difenacoum
    • 8.2.4. Difethialone
    • 8.2.5. Flocoumafen

9. Anticoagulant Rodenticides Market, by Formulation

  • 9.1. Blocks
  • 9.2. Grain
  • 9.3. Liquid
  • 9.4. Paste
  • 9.5. Pellets

10. Anticoagulant Rodenticides Market, by Mode Of Action

  • 10.1. Coumarin
    • 10.1.1. Brodifacoum
    • 10.1.2. Bromadiolone
    • 10.1.3. Coumatetralyl
    • 10.1.4. Difenacoum
    • 10.1.5. Difethialone
    • 10.1.6. Flocoumafen
    • 10.1.7. Warfarin
  • 10.2. Indanedione
    • 10.2.1. Chlorophacinone
    • 10.2.2. Diphacinone
    • 10.2.3. Pindone

11. Anticoagulant Rodenticides Market, by Target Rodent

  • 11.1. Mice
  • 11.2. Rats
  • 11.3. Squirrels
  • 11.4. Voles

12. Anticoagulant Rodenticides Market, by End User

  • 12.1. Agricultural
  • 12.2. Commercial
  • 12.3. Industrial
  • 12.4. Municipal
  • 12.5. Residential

13. Anticoagulant Rodenticides Market, by Application Method

  • 13.1. Bait Stations
  • 13.2. Burrow Baiting
  • 13.3. Liquid Baiting
  • 13.4. Loose Bait

14. Anticoagulant Rodenticides Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Anticoagulant Rodenticides Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Anticoagulant Rodenticides Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. BASF SE
    • 17.3.2. Bayer AG
    • 17.3.3. Neogen Corporation
    • 17.3.4. PelGar International PLC
    • 17.3.5. Syngenta AG
    • 17.3.6. FMC Corporation
    • 17.3.7. UPL Limited
    • 17.3.8. Adama Agricultural Solutions Ltd.
    • 17.3.9. Sumitomo Chemical Co., Ltd.
    • 17.3.10. Sichuan Sunshine Biotech Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. ANTICOAGULANT RODENTICIDES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. ANTICOAGULANT RODENTICIDES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ANTICOAGULANT RODENTICIDES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BLOCKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BLOCKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BLOCKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BLOCKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BLOCKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BLOCKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY GRAIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY GRAIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY GRAIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY GRAIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY GRAIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY GRAIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PASTE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PASTE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PASTE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PASTE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PASTE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PASTE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PELLETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PELLETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PELLETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PELLETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PELLETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PELLETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SQUIRRELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SQUIRRELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SQUIRRELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SQUIRRELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SQUIRRELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SQUIRRELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY VOLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY VOLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY VOLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY VOLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY VOLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY VOLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY AGRICULTURAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY AGRICULTURAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY AGRICULTURAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY AGRICULTURAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY AGRICULTURAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COMMERCIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COMMERCIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COMMERCIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDUSTRIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDUSTRIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDUSTRIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDUSTRIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDUSTRIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MUNICIPAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MUNICIPAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MUNICIPAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MUNICIPAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MUNICIPAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MUNICIPAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RESIDENTIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RESIDENTIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RESIDENTIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RESIDENTIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RESIDENTIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RESIDENTIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BAIT STATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BAIT STATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BAIT STATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BAIT STATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BAIT STATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BAIT STATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BURROW BAITING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BURROW BAITING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BURROW BAITING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BURROW BAITING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BURROW BAITING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BURROW BAITING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID BAITING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID BAITING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID BAITING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID BAITING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID BAITING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID BAITING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LOOSE BAIT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LOOSE BAIT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LOOSE BAIT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LOOSE BAIT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LOOSE BAIT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LOOSE BAIT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2025-2032 (USD MILLION)
  • TABLE 287. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 288. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 289. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
  • TABLE 290. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2025-2032 (USD MILLION)
  • TABLE 291. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, 2018-2024 (USD MILLION)
  • TABLE 292. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, 2025-2032 (USD MILLION)
  • TABLE 293. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, 2018-2024 (USD MILLION)
  • TABLE 294. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, 2025-2032 (USD MILLION)
  • TABLE 295. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2018-2024 (USD MILLION)
  • TABLE 296. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2025-2032 (USD MILLION)
  • TABLE 297. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 300. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2018-2024 (USD MILLION)
  • TABLE 306. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2025-2032 (USD MILLION)
  • TABLE 307. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2018-2024 (USD MILLION)
  • TABLE 308. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2025-2032 (USD MILLION)
  • TABLE 309. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)

TABL